A 28-week randomized clinical trial has shown a significant increase in the overall satisfaction (measured by the DTSQs) in patients with type 1 diabetes mellitus treated with insulin analogues compared with decreased satisfaction in patients treated with human insulin (score difference between treatments 1.83 points, p < 0.001) (19). This evidence concerns the gene INS and type 1 diabetes mellitus.